Imugene Doses First Patient of Bile Tract Cancer in Phase One Clinical Trial; Shares Decline 6%
Imugene Doses First Patient of Bile Tract Cancer in Phase One Clinical Trial; Shares Decline 6%
Imugene在一期臨床試驗中爲膽道癌的第一個患者進行治療；股價下跌6%。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊